![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgoSwKSWJSSqhIok0jemnwg-Uq_uezXIYWX1GLxPHmaEE7OBjW8iWaWVgjtl8EJYlOUho1AJa75ITAr49lsqC_4RibTaOkQq6I9yWobxhFmKVPnZVkH4plEm1AwK7fwkWrJgEiA/s320/00114.resized.jpg)
The 13th Paneuropean Congress of European Association of Hospital Pharmacists, organised in Maastricht 27-29 February 2008, was completed with a great success.
The program had a lot of seminars, conferences and posters presentations. Here you can find some photographic snapshots from the congress (you can click
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEged1kveqrcXm9N-l-YeOaZ0HPQKAKCgUp20sz2x81mR4si_f0hXvJQ_bXJKfnt8DXfMqJI3LiEyxFfU3Y71n02eWg6vk8T11YEAKzMbp3Zx8V31nNGzUKNohr7A19s2vkkYdVxzw/s320/141-fin.jpg)
- 'The role and added value of the hospital pharmacist in health care: beyond Napoleon’s buttons’, Professor Hubert G. Leufkens, Utrecht Institute for Pharmaceutical Sciences (UIPS) and the Dutch Medicines Evaluation Board (MEB), The Netherlands
- ‘The importance of the hospital Pharmacist as a member of the clinical pharmaceutic team’ Professor Lars Heslet, National University Hospital, Rigshospitalet, Copenhagen, Denmark
- ‘The Role and added value of the hospital pharmacist in improving the safety of medicines in health care’ Mr Donald Hughes, Conway & Denbighshire NHS Trust, Rhyl, United Kingdom
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjWgW-lFVJmMLooMIhkZltmATR_Jfkt49Nq21-3jAprGrPmRhYI5cFjlip8Nj-XmaYwM41lqxup9zzv5T1x5RuuqA2UKxiwvHuhyphenhyphenRJv40XDoUn34y4slc-hnFxSn_DY-59eFMKR/s320/00147.resized.jpg)
1: Handling gene therapy drugs in Europe
Speaker A: Dr Nicola Stoner, Cancer Research UK, Oxford, UK
Speaker B: Dr Andras Vermes, Erasmus University Medical Center, Rotterdam,The Netherlands
2: Hospital pharmacies make medicines available
Speaker A: Mr Reinout Schellekens, University Medical Centre Groningen, Groningen, The Netherlands
Speaker B: Professor Jan Raaijmakers, GlaxoSmithKline / Utrecht University, Utrecht, The Netherlands
3: Pharmacovigilance: added value of hospital pharmacists
Speaker A: Dr Kees van Grootheest, Dutch Pharmacovigilance Centre LAREB, ’s-Hertogenbosch, The Netherlands
Speaker B: Professor Gordon Schiff, Cook County Hospital, Chilcago, IL, USA
4: Measuring the added value of hospital pharmacy processes
Speaker A: Dr Antonio Melo Gouveia, National Oncology Institute, Lisbon, Portugal
Speaker B: Dr Marianne Ivey, The Health Alliance, Cincinnati OH, USA
Speaker C: Pieter Knoester, Rijnland Ziekenhuis, Leiderdorp, The Netherlands
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjRa1Ut2DhMRPqVjHfxWkc0p-4UePFZ0zYdJdIUdOo101JXk2In4NvSXJ5Gtfahyphenhyphen-LaMv2M0mpJcnaFuF_tqKwgL4xuzMtm-0uMGmsAwcEkCZpYiogqOlzcnOZRV4y1Dh91YmfN/s320/00153.resized.jpg)
Speaker A: Professor Per Hartvig, Copenhagen University, Copenhagen, Denmark
Speaker B: Dr Alistair Millar, The Royal Infirmary of Edinburgh, Edinburgh, United Kingdom
6: The role of the hospital pharmacist in psychiatry
Speaker A: Dawn Price, Northumberland Tyne and Wear NHS Trust, Cherry Knowle Hospital Ryhope, Sunderland, UK
Speaker B: Elisabeth Eide, Haukeland Hospital Pharmacy, Bergen, Norway
Speaker C: Hans Mulder, Wilhelmina Hospital, Assen, The Netherlands
Speaker D: Francisco Martínez-Granados, Alicante General Hospital, Alicante, Spain
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjom1xyJ6L40ggUNTDKbrmxoF4pA-Cd8sKT0RdJQoV8T6p15jHZU8Lrorh_bqtJbQTvjT9qEsnHb2Nr5haD9ekFBAz5KrzZdZPZ4BqZG94jj_W9Ih_cB9L7DQkqyNDbIp0TxTaw/s320/00154.resized.jpg)
Speaker A: Mrs Rowena McArtney, University Hospital of Wales, Cardiff, United Kingdom
Speaker B: Mrs Nathalie Seigneuret, Paediatric Medicines and Orphan Drugs Sector, Pre-authorisation Evaluation of Medicines for Human Use Unit, London, United Kingdom
8: Patient safety in Europe
Speaker A: Dr Susan Proulx, Med-E.R.R.S., Huntington Valley PA, USA
Speaker B: Mr Brian Bjørn, Hvidovre Hospital, Capital Region, Copenhagen, Denmark
9: The value of the hospital pharmacist in the prescribing process
Speaker A: René Groulsch, Catharina Hospital, Eindhoven, The Netherlands
Speaker B: Nicola Wake, Nicola Wake, Northumbria Healthcare NHS Foundation Trust, Tyne & Wear, United Kingdom
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEixF7V4V3eJvpgRbft1BB5n4uBGJSWzS31fB80a5_-zDd_VqoIK83vou9cyT28e3aOemEM6NgMWC0Je2QNChOr2_u55MOB_jT81GMdyKfyuQDesLQJeFfpBx9nsgzIcdzGjbKLT/s320/00155.resized.jpg)
Speaker A: Dr Frits Elferink, Royal Dutch Association for the advancement of Pharmacy, The Hague, The Netherlands
Speaker B: Jenneke Wijbenga, Royal Dutch Association for the Advancement of Pharmacy, The Hague, The Netherlands
Speaker C: Dr Mirjam Rommers, Leiden University Hospital, Leiden, The Netherlands
Speaker D: Mr Jan Bruin, National IT Institute for Healthcare in the Netherlands (NICTIZ, The Hague, The Netherlands
11: National delegates seminar: e-Health solutions in hospital pharmacy
Speaker A: Mrs Inger Bjeldbak-Olesen, Hospital Pharmcy Roskilde, Denmark
Speaker B: Professor Ann Jacklin, Hammersmith Hospitals NHS Trust, UK
12: Collaboration and standards for small hospital pharmacies
Speaker A: Dr Marie Rancakova, Czech Republic
Speaker B: Mrs Gitte Søndergaard Nielsen, Næstved Hospital Pharmacy, Næstved
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgJm06gLKi76oVOgYBGQJBy-U-BhIO9aMyFrGvlZe000npRIWnDxeDnt1MYPhcmLBRMi7uEyPbb_MmxsixgZJzlp8hV0RUDkUTs2bo-lskS81SsikGXLGf3kOaRrLlWM8snlQ-9/s320/00146.resized.jpg)
Satellite Symposia
1: Breaking new grounds in i.v, iron Therapy, VIFOR INTERNATIONAL
2: Drug-Eluting Beads: A new therapy for Hepatic Tumours. Clinical and Pharmaceutical assessment, BIOCOMPATIBLES/TERUMO
3: Quality and safety in pharmaceutical preparation of cytotoxic drugs, BERNER
4: Biogenerics: from promise to reality in Europe, TEVA
5: SafeChemo: ePrescription and Automation for a Safe Management of Cytostatics, B.BRAUN
6: Navigating Risk Management, IDIS
7: GMP Compliant Qualified Software in the Hospital Pharmacy – Supplier Supported Software Validation in Practice, CATO SOFTWARE SOLUTIONS
8: The biopharmaceuticals revolution: latest advances and challenges for hospital pharmacists, AMGEN
9: Round table: Biosimilars in clinical practice – The challenges for Hospital Pharmacists, AMGEN